Medtronic gets FDA nod for blood sugar monitoring device
Jan 29 (Reuters) - Medtronic Inc (MDT.N: Quotazione) said U.S. health regulators approved its blood sugar monitoring device, the CGMS iPro Recorder.
The U.S. medical device maker said patients wear the device for three days, after which physicians can review the data and use the results to uncover glucose patterns. (Reporting by Avishek Mishra in Bangalore; Editing by Himani Sarkar)
© Thomson Reuters 2017 Tutti i diritti assegna a Reuters.